Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 29 | ICEECE2012 | Next issue

15th International & 14th European Congress of Endocrinology

Symposia

Current progress in the management of thyroid cancer

Previous section
European network for the study of adrenal tumours (ENSAT)
Table of contents
Next section
Young Active Researchers Symposium (YAR)

ea0029s69.1 | Current progress in the management of thyroid cancer | ICEECE2012

TSH suppression in differentiated thyroid cancer: how low should we go?

Cooper D.

Suppression of serum thyrotropin (TSH) is a cornerstone of thyroid cancer treatment, due to the tropic effects of TSH on thyroid cells. However, when deciding on the degree of TSH suppression during initial and long-term management, it is necessary to consider the aggressiveness of the cancer, as well as the potential for adverse effects induced by iatrogenic subclinical or overt hyperthyroidism. More aggressive TSH suppression is indicated in patients with high-risk disease o...
0 shares

ea0029s69.2 | Current progress in the management of thyroid cancer | ICEECE2012

Abstract unavailable....
0 shares

ea0029s69.3 | Current progress in the management of thyroid cancer | ICEECE2012

Abstract unavailable....
0 shares

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more